KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) EBT Margin (2016 - 2025)

Historic EBT Margin for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to 10.42%.

  • BeOne Medicines' EBT Margin rose 202300.0% to 10.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.67%, marking a year-over-year increase of 277400.0%. This contributed to the annual value of 13.99% for FY2024, which is 196000.0% up from last year.
  • BeOne Medicines' EBT Margin amounted to 10.42% in Q3 2025, which was up 202300.0% from 7.57% recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' EBT Margin ranged from a high of 29.35% in Q3 2023 and a low of 320.4% during Q2 2021
  • Moreover, its 5-year median value for EBT Margin was 55.29% (2023), whereas its average is 82.3%.
  • Its EBT Margin has fluctuated over the past 5 years, first surged by 7082400bps in 2021, then plummeted by -1475900bps in 2022.
  • Over the past 5 years, BeOne Medicines' EBT Margin (Quarter) stood at 283.22% in 2021, then soared by 60bps to 113.38% in 2022, then surged by 51bps to 55.29% in 2023, then surged by 86bps to 7.57% in 2024, then surged by 238bps to 10.42% in 2025.
  • Its EBT Margin was 10.42% in Q3 2025, compared to 7.57% in Q2 2025 and 1.87% in Q1 2025.